BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32790156)

  • 1. Insurance Status as a Predictor of Treatment in Human Papillomavirus Positive Oropharyngeal Cancer.
    Berger MH; Yasaka TM; Haidar YM; Kuan EC; Tjoa T
    Laryngoscope; 2021 Apr; 131(4):776-781. PubMed ID: 32790156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients.
    Settle K; Posner MR; Schumaker LM; Tan M; Suntharalingam M; Goloubeva O; Strome SE; Haddad RI; Patel SS; Cambell EV; Sarlis N; Lorch J; Cullen KJ
    Cancer Prev Res (Phila); 2009 Sep; 2(9):776-81. PubMed ID: 19641042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National treatment trends in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Zhan KY; Puram SV; Li MM; Silverman DA; Agrawal AA; Ozer E; Old MO; Carrau RL; Rocco JW; Higgins KM; Enepekides DJ; Husain Z; Kang SY; Eskander A
    Cancer; 2020 Mar; 126(6):1295-1305. PubMed ID: 31825543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Socioeconomic and Racial Disparities and Survival of Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma.
    Rotsides JM; Oliver JR; Moses LE; Tam M; Li Z; Schreiber D; Jacobson AS; Hu KS; Givi B
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):131-138. PubMed ID: 32660368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
    Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Mizumachi T; Kano S; Sakashita T; Hatakeyama H; Suzuki S; Homma A; Oridate N; Fukuda S
    Int J Clin Oncol; 2013 Oct; 18(5):824-8. PubMed ID: 22936564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
    Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
    Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma.
    Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J
    Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV Status and Survival in Non-Oropharyngeal Squamous Cell Carcinoma of the Head and Neck.
    Wookey VB; Appiah AK; Kallam A; Ernani V; Smith LM; Ganti AK
    Anticancer Res; 2019 Apr; 39(4):1907-1914. PubMed ID: 30952732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transoral Resection of Human Papillomavirus (HPV)-Positive Squamous Cell Carcinoma of the Oropharynx: Outcomes with and Without Adjuvant Therapy.
    Jackson RS; Sinha P; Zenga J; Kallogjeri D; Suko J; Martin E; Moore EJ; Haughey BH
    Ann Surg Oncol; 2017 Nov; 24(12):3494-3501. PubMed ID: 28808988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas.
    Sedaghat AR; Zhang Z; Begum S; Palermo R; Best S; Ulmer KM; Levine M; Zinreich E; Messing BP; Gold D; Wu AA; Niparko KJ; Kowalski J; Hirata RM; Saunders JR; Westra WH; Pai SI
    Laryngoscope; 2009 Aug; 119(8):1542-9. PubMed ID: 19522004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer.
    Kamran SC; Qureshi MM; Jalisi S; Salama A; Grillone G; Truong MT
    Laryngoscope; 2018 Jun; 128(6):1353-1364. PubMed ID: 28988426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
    Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
    Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.